FDA Warning Letter — Navinta, LLC

Case 498400 — FEI 3004375014

The FDA took a Warning Letter action against Navinta, LLC on Sep 26, 2016 (Ewing, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Navinta, LLC
Date
Sep 26, 2016
Fiscal Year
2016
Product Type
Drugs
Center
CDER
Location
Ewing, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.